Tilray Inc. (TLRY)
Symbol Info
Listed Symbol TLRY
Name Tilray Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $43,130,000
Latest Fiscal EPS $-0.83
Price Info
21 Day Moving Average $29.5610
21 Day EMA $31.154550
50 Day Moving Average $36.0122
50 Day EMA $35.051630
200 Day EMA $50.199530
200 Day Moving Average 56.878850
52 Week High $178.85
52 Week Low $25.15
52 Week Change $-83.555400
Alpha 0.112778
Beta 4.4474
Standard Deviation 0.656166
R2 0.116921
Periods 14
Share Information
10 Day Average Volume 1,503,263
20 Day Average Volume 2,081,635
30 Day Average Volume 2,416,841
50 Day Average Volume 1,798,139
Outstanding Shares 97,644,963
Float Shares 97,236,232
Percent Float 99.58%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 249
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 546,605
Institute Holdings Percent 67.200000
Institute Sold Previous 3 Months 281,606
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 408,731
Price Change
7 Day Price Change $-2.6499996
7 Day Percent Change -8.37%
21 Day Price Change $3.3300000
21 Day Percent Change 12.97%
30 Day Price Change $-0.2999992
30 Day Percent Change -1.02%
Month To Date Price Change $3.3300
Month To Date Percent 12.97%
90 Day Price Change $-20.71
90 Day Percent Change -41.66%
Quarter To Date $-17.560001
Quarter To Date Percent -37.71%
180 Day Price Change $-41.730003
180 Day Percent Change -59.00%
200 Day Price Change $-48.25
200 Day Percent Change -62.46%
Year To Date $-41.54
Year To Date Percent -58.89%
Profile
Description Tilray, headquartered in Nanaimo, Canada cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. through a partnership with Authentic Brands Group and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a partnership with AB InBev to develop cannabis-infused drinks.
Details
Issue Type CS
Market Cap $2,831,703,927
Sec Type
Auditor Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)
Total Shares Outstanding 97,644,963
CEO Brendan Kennedy
Employees 688
Last Audit UQ
Classification
CIK 0001731348
Industry Drug Manufacturers
Sector Healthcare
NAICS Medicinal and Botanical Manufacturing(325411)
Info
Address 1100 Maughan Road
Nanaimo, BC V9X IJ2
Website http://www.tilray.com
Facisimile +1 888 783-1323
Telephone +1 844 845-7291
Email katie.turner@icrinc.com
Key Ratios
Profitability
EBIT Margin -102
EBITDA Margin -93.4
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin 25.20
Profit Margin TOT -
Income Statements
Revenue $94,520,000
Revenue Per Share $1.1542
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $3,190,028,472
Price To Sales 25.126398
Price To Free Cash -8.9
PE High Last 5 Years -
Price To Book 8.4
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book -23.7
Financial Strength
Total Debt To Equity 1.2
Int Coverage -
Current Ratio 2.0
Leverage Ratio 2.6
Quick Ratio 1.4
Long Term Debt To Capital 0.55
Assets
Receivables Turnover 5.1
Invoice Turnover 1.70
Assets Turnover 0.10
Management Effectiveness
Return Assets -20.35
Return On Equity -58.2
Return On Capital -26.01
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
TLRY
Tilray
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.